| URL | https://endpts.com/a-california-biotech-steps-into |
| Source | Endpoints News |
| Date Published | 10/14/2021 |
| Mentions specific company case(s) of reshoring, kept from offshoring, or transplant | Yes |
| Company/Division name | Avid Bioservices |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Year reshoring announced: | 2021 |
| Year reshoring implemented or to be implemented: | 2023 |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 75 |
| City reshored to: | Tustin |
| State(s) reshored to: | CA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | CDMO, cell and gene therapy, viral vector cGMP man |